Primecap Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-435,870
| Closed | -$40.5M | – | 346 |
|
|
2021
Q4 | $40.5M | Sell |
435,870
-55,930
| -11% | -$3.68M | 0.03% | 203 |
|
|
2021
Q3 | $29.3M | Sell |
491,800
-5,000
| -1% | -$295K | 0.02% | 217 |
|
|
2021
Q2 | $33.9M | Sell |
496,800
-7,290
| -1% | -$475K | 0.02% | 216 |
|
|
2021
Q1 | $35M | Sell |
504,090
-7,410
| -1% | -$570K | 0.02% | 209 |
|
|
2020
Q4 | $39.3M | Sell |
511,500
-19,200
| -4% | -$1.44M | 0.03% | 194 |
|
|
2020
Q3 | $39.7M | Sell |
530,700
-23,870
| -4% | -$1.59M | 0.03% | 182 |
|
|
2020
Q2 | $34.9M | Sell |
554,570
-25,430
| -4% | -$1.4M | 0.03% | 179 |
|
|
2020
Q1 | $24.4M | Sell |
580,000
-711,000
| -55% | -$32.6M | 0.02% | 184 |
|
|
2019
Q4 | $58.6M | Sell |
1,291,000
-75,000
| -5% | -$3.55M | 0.04% | 163 |
|
|
2019
Q3 | $62.5M | Sell |
1,366,000
-159,200
| -10% | -$8.95M | 0.05% | 157 |
|
|
2019
Q2 | $89.4M | Buy |
1,525,200
+63,000
| +4% | +$3.26M | 0.07% | 150 |
|
|
2019
Q1 | $65.5M | Sell |
1,462,200
-1,800
| -0.1% | -$82.6K | 0.05% | 165 |
|
|
2018
Q4 | $57M | Buy |
1,464,000
+475,601
| +48% | +$18.7M | 0.05% | 168 |
|
|
2018
Q3 | $45.5M | Buy |
+988,399
| New | +$40.1M | 0.03% | 187 |
|
Primecap Management's ARNA Position: Q1 2022 in Review
Primecap Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 435,870 shares — an estimated $40.5M sold.
Primecap Management first reported a position in ARNA in Q3 2018 and held it in 14 quarters. The position peaked at $89.4M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Primecap Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Primecap Management sold 435,870 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $40.5M.
- Primecap Management first reported a position in Arena Pharmaceuticals Inc in Q3 2018 and held it in 14 quarters.
- Primecap Management's Arena Pharmaceuticals Inc position peaked at $89.4M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Primecap Management's 13F filing for Q1 2022, filed 11 May 2022.